Pediatric, Adolescent, & Maternal Therapeutics
This section provides an international forum for dialogue on matters regarding the tolerability and effective drug therapy in neonates, infants, children, adolescents, and pregnant or lactating women. Manuscripts dealing with the developmental and genetic basis for drug responsiveness are highly encouraged. Because of the rapid publication process, time-sensitive topics are of particular interest. Published manuscripts include review articles, original contributions, brief reports, and commentaries. All manuscripts are peer reviewed for clinical relevance, technical accuracy, clarity, and objectivity.
Published manuscripts include:
- Pediatric and maternal clinical trials, including pharmacoeconomic studies
- Reviews discussing the unique characteristics of pregnant women, fetuses, children, and adolescents regarding the drug development process
- Studies of pediatric and maternal formulations
- Pharmacokinetic/pharmacodynamic modeling studies involving pediatric and pregnant patients
- Objective measures of responses in pediatric and maternal patients (eg, quality of life)
- Therapeutic and/or toxic-effect monitoring in pediatric and pregnant populations (eg, case control, cohort, etc)
- Adverse events in pediatric and pregnant patients
- Attitudes or actions of parents or family members and/or pediatric and pregnant patients involving the use of therapeutic interventions
- Developmental pharmacology studies (human or animal)
- Developmental physiology studies (eg, taste, pulmonary function, skin absorption) relating to pediatric and maternal therapeutics
- Ethics of studies in pediatric and pregnant patients, including the informed consent process
- Clinical trial designs for pediatric and pregnant patient populations
- Studies in neonates, infants, children, adolescents, and pregnant or lactating women
- Developmental and genetic basis for drug responsiveness
